8-Amino-3-benzyl-1,2,4-triazolo[4,3-a]pyrazines. Synthesis and anticonvulsant activity. 1995

J L Kelley, and J A Linn, and D D Bankston, and C J Burchall, and F E Soroko, and B R Cooper
Division of Organic Chemistry, Burroughs Wellcome Co., Research Triangle Park, North Carolina 22709, USA.

Eleven substituted 8-amino-3-benzyl-1,2,4-triazolo[4,3-a] pyrazines were synthesized and tested for anticonvulsant activity against maximal electroshock-induced seizures (MES) in rats. The compounds were prepared in four stages from the phenylacetonitriles. I. The intermediate (2,2,2-triethoxyethyl)benzenes III were condensed with 2-chloro-3-hydrazinopyrazine (IV) to provide the 3-benzyl-8-chloro-1,2,4-triazolo[4,3-a]pyrazines V. The latter were converted to the 8-amine targets VI with methylamine or ammonia. Several compounds exhibited potent activity against MES; the 3-(2-fluorobenzyl)-8-(methylamino) and 3-(2,6-difluorobenzyl)-8-(methylamino)congeners (4 and 12) exhibited the best anticonvulsant activity with oral ED50S of 3 mg/kg. The 1,2,4-triazolo[4,3-a]pyrazine ring system serves as a bioisostere of the purine ring for anticonvulsant activity; however, these agents exhibit less propensity to cause emesis.

UI MeSH Term Description Entries
D008297 Male Males
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

J L Kelley, and J A Linn, and D D Bankston, and C J Burchall, and F E Soroko, and B R Cooper
April 2024, Chemistry (Weinheim an der Bergstrasse, Germany),
J L Kelley, and J A Linn, and D D Bankston, and C J Burchall, and F E Soroko, and B R Cooper
December 2008, Archiv der Pharmazie,
J L Kelley, and J A Linn, and D D Bankston, and C J Burchall, and F E Soroko, and B R Cooper
February 2013, Archiv der Pharmazie,
J L Kelley, and J A Linn, and D D Bankston, and C J Burchall, and F E Soroko, and B R Cooper
November 2005, Bioorganic & medicinal chemistry letters,
J L Kelley, and J A Linn, and D D Bankston, and C J Burchall, and F E Soroko, and B R Cooper
May 2010, European journal of medicinal chemistry,
J L Kelley, and J A Linn, and D D Bankston, and C J Burchall, and F E Soroko, and B R Cooper
April 2011, European journal of medicinal chemistry,
J L Kelley, and J A Linn, and D D Bankston, and C J Burchall, and F E Soroko, and B R Cooper
March 2009, European journal of medicinal chemistry,
J L Kelley, and J A Linn, and D D Bankston, and C J Burchall, and F E Soroko, and B R Cooper
July 1984, Journal of medicinal chemistry,
J L Kelley, and J A Linn, and D D Bankston, and C J Burchall, and F E Soroko, and B R Cooper
July 2005, Biological & pharmaceutical bulletin,
J L Kelley, and J A Linn, and D D Bankston, and C J Burchall, and F E Soroko, and B R Cooper
August 2012, Arzneimittel-Forschung,
Copied contents to your clipboard!